NBTX Nanobiotix S.A.

Nasdaq nanobiotix.com


$ 20.79 $ 0.00 (0 %)    

Thursday, 23-Oct-2025 05:24:07 EDT
QQQ $ 605.97 $ 0.00 (0 %)
DIA $ 465.29 $ 0.00 (0 %)
SPY $ 668.27 $ 0.00 (0 %)
TLT $ 91.54 $ 0.00 (0 %)
GLD $ 378.90 $ 0.00 (0 %)
$ 22.18
$ 23.40
$ 20.93 x 500
$ 21.09 x 500
-- - --
$ 2.76 - $ 30.35
134,365
na
1.05B
$ 0.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nanobiotix-announces-first-data-from-cohorts-1-and-2-of-dose-escalation-part-of-phase-1-study-evaluating-jnj-1900-for-eadc-patients

Treatment was well-tolerated and injection feasibility was confirmed in 13 patients with locally advanced adenocarcinoma of the...

 nanobiotix-h1-eps-012-up-from-050-yoy-sales-30202m-up-from-10001m-yoy

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.12) per share. This is a 76 percent increase over losses of $(0.50) p...

 nanobiotix-jj-therapy-shows-promise-in-tough-head-and-neck-cancer

Nanobiotix reported updated Phase 1 trial data for JNJ-1900 in head and neck cancer, showing strong disease control and surviva...

 reported-earlier-nanobiotix-reports-updated-phase-1-data-showing-jnj-1900-nbtxr3-plus-anti-pd-1-achieves-37-orr-and-63-dcr-in-nave-rm-hnscc-patients

Treatment remained well-tolerated with consistent injection feasibility in 103 heavily pre-treated patients with R/M-HNSCC naïv...

 stitch-fix-posts-q4-results-joins-transocean-mbx-biosciences-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc....

 why-pepgen-shares-are-trading-higher-by-112-here-are-20-stocks-moving-premarket

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritt...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION